Events

Register here!

NVTAG webinar: The GRADE framework and its application in reimbursement decision making GRADE (Grading of Recommendations, Assessment, Development, and Evaluations) is a transparent framework for developing and presenting summaries of evidence and provides a systematic approach for making clinical practice recommendations. It is the most widely adopted tool for grading the quality of evidence and […]

Date: April 3, 2025 Time: 12:30 - 17:30 Location: Domstad Utrecht There is a shortage of staff in healthcare. This requires looking beyond the normal aspects such as effectiveness and costs when making decisions in healthcare. A temporary committee appointed by the Zorginstituut Nederland recently considered the question of how to include ‘labour input’ as […]

NVTAG Webinar: The Use of AI in HTA Artificial Intelligence (AI) is increasingly shaping the way we generate and assess evidence in health technology assessment (HTA). But what are the implications for policy and practice? Join us for this NVTAG webinar, where experts from iMTA, and ZIN will share their perspectives on the opportunities, challenges, […]

The programme's general structure encompasses an examination of quality of life measurements and EuroQol in general. It also includes an exploration of the development of value sets and a comparison of the EQ5D-5L and EQ5D-3L models, along with the implications of these differences. The programme will also examine the role of quality of life measurements […]

The updated Dutch guideline for economic evaluations in healthcare was released in January 2024 by the Dutch Healthcare Institute (ZIN) to provide a clear framework for assessing new healthcare technologies from a broad societal perspective. The guideline recommends to use Structured Expert Elicitation when faced uncertainty in economic models. The Dutch Society for Health Technology […]

Always wanted to learn about distributional cost effectiveness analysis. Do not miss out to learn from the experts during this Young NVTAG webinar. Register here to secure entrance to the webinar.

At the request of the Ministry of Health, Welfare and Sport (VWS), the MAUG program (programma ‘Maatschappelijk Aanvaardbare Uitgaven Geneesmiddelen’) examined how to obtain societally acceptable prices for expensive medicines and keep them that way. Within the program three independent governmental bodies (Zorginstituut Nederland, Nederlandse Zorgautoriteit and Autoriteit Consument & Markt) worked together for the […]

From early HTA to sustainable Access: Navigating financing and reimbursement challenges for expensive care On April 9, 2026, join the Dutch Association for Technology Assessment in Healthcare (NVTAG) for a symposium dedicated to the evolving journey of healthcare innovations. This year, we close the loop by connecting early HTA  to the challenges of financing and reimbursement. […]